HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PD-0200347

a ligand reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Boileau, Christelle: 1 article (02/2005)
2. Schrier, Denis: 1 article (02/2005)
3. Boily, Martin: 1 article (02/2005)
4. Pelletier, Jean-Pierre: 1 article (02/2005)
5. El-Kattan, Ayman: 1 article (02/2005)
6. Martel-Pelletier, Johanne: 1 article (02/2005)
7. Flory, Craig: 1 article (02/2005)
8. Brunet, Julie: 1 article (02/2005)
9. Tardif, Ginette: 1 article (02/2005)

Related Diseases

1. Osteoarthritis

Related Drugs and Biologics

1. Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
2. Metalloproteases (Metalloproteinases)
3. pregabalin (Lyrica)
4. gabapentin (Neurontin)